Skip to content

We're in Beta! Found a bug? Let us know using the feedback button at the bottom right.

FolioFact
FolioFact
Q3 2026 56/68 funds filed
Latest observation
Sign in Sign up

Some record dates are in the future and are excluded from the latest observation date.

Stock overview

Perspective Therapeutics Inc - US

Explore the company, reported ownership, price history, and available source evidence.

Perspective Therapeutics Inc (CATX) is a healthcare or biotechnology equity security tracked from 13F filings.

Last close
$0.78
· CATX
Tracked holders
2 funds
Latest available 13F per fund
Latest 13F filed
Review reported holdings

CATX · USD

Price

$0.78 -$1.50 (-65.79%) over selected range

Close · Nov 18, 2026

Market closed 252 stored daily closes
$0.78 Nov 18, 2026
CATX 1Y closing price chart 252 stored daily closes from Nov 18, 2025–Nov 18, 2026. Low $0.78; high $5.65.
Nov 18, 2025May 19, 2026Nov 18, 2026
Range low
$0.78
Range high
$5.65
Observations
252
Session date
Nov 18, 2026

Nov 18, 2025–Nov 18, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.

Investor Popularity

Rows are narrowed by movement, fund type, and position size.

2 holders
Fund Move Value Weight
Renaissance Technologies largest tracked holder Q3 2026 · filed Nov 12, 2026 · SEC filing +275% 26'Q3 $609,491 0%
Tudor Investment Corp position history Q3 2026 · filed Nov 16, 2026 · SEC filing +86% 26'Q3 $92,714 0%

SEC Forms 4/5

Insiders

Reported trades

Financials

Official-source analysis

AI Earnings Report

View all AI Earnings Reports

No published AI Earnings Report yet

We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.

Options market

Options

IV30 · daily

Send feedback

Optional — tap one if it fits

We'll only use this to respond to your feedback.